Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Alcoholic liver disease 💬
 [1] IL17A 💬 Bimekizumab 💬 Bimekizumab [3] 46, 97, 271 💬
2 Alcoholic liver disease 💬
 [1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
3 Alcoholic liver disease 💬
 [1] IL17A 💬 Secukinumab 💬 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271 💬
4 Alcoholic liver disease 💬
 [1] IL17A 💬 Tibulizumab 💬 Tibulizumab [1] 53 💬
5 Cytokine-cytokine receptor interaction 💬
 [1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
6 Cytokine-cytokine receptor interaction 💬
 [1] IL17A 💬 Secukinumab 💬 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271 💬
7 Cytokine-cytokine receptor interaction 💬
 [2] IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab [3] 46, 97, 271 💬
8 Cytokine-cytokine receptor interaction 💬
 [2] IL17A, TNFSF13B 💬 Tibulizumab 💬 Tibulizumab [1] 53 💬
9 IL-17 signaling pathway 💬
 [1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
10 IL-17 signaling pathway 💬
 [1] IL17A 💬 Secukinumab 💬 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271 💬
11 IL-17 signaling pathway 💬
 [1] IL17A 💬 Tibulizumab 💬 Tibulizumab [1] 53 💬
12 IL-17 signaling pathway 💬
 [2] IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab [3] 46, 97, 271 💬
13 Inflammatory bowel disease 💬
 [1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
14 Inflammatory bowel disease 💬
 [1] IL17A 💬 Secukinumab 💬 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271 💬
15 Inflammatory bowel disease 💬
 [1] IL17A 💬 Tibulizumab 💬 Tibulizumab [1] 53 💬
16 Inflammatory bowel disease 💬
 [2] IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab [3] 46, 97, 271 💬
17 Rheumatoid arthritis 💬
 [1] IL17A 💬 Bimekizumab 💬 Bimekizumab [3] 46, 97, 271 💬
18 Rheumatoid arthritis 💬
 [1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
19 Rheumatoid arthritis 💬
 [1] IL17A 💬 Secukinumab 💬 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271 💬
20 Rheumatoid arthritis 💬
 [2] IL17A, TNFSF13B 💬 Tibulizumab 💬 Tibulizumab [1] 53 💬
21 Th17 cell differentiation 💬
 [1] IL17A 💬 Ixekizumab 💬 Ixekizumab [8] 36, 37, 46, 107, 160, 162, 269, 271 💬
22 Th17 cell differentiation 💬
 [1] IL17A 💬 Secukinumab 💬 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271 💬
23 Th17 cell differentiation 💬
 [1] IL17A 💬 Tibulizumab 💬 Tibulizumab [1] 53 💬
24 Th17 cell differentiation 💬
 [2] IL17A, IL17F 💬 Bimekizumab 💬 Bimekizumab [3] 46, 97, 271 💬

Back to top